Ibrutinib In Previously Untreated High-risk Smoldering Mcl: Insights From A Phase Ii Trial

2025 3:29
Synopsis
Charles Gaulin, MBBS, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses a Phase II clinical trial ...

You Might Also Like

Ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed MCL 1:21
Ibrutinib, Rituximab And Venetoclax In The Treatment Of Pati...
2023
Acalabrutinib in combination with umbralisib and ublituximab in previously untreated MCL 1:27
Acalabrutinib In Combination With Umbralisib And Ublituximab...
2024
Phase II trial of acalabrutinib, lenalidomide and rituximab in patients with MCL 5:12
Phase Ii Trial Of Acalabrutinib, Lenalidomide And Rituximab ...
2024
Copanlisib for People with MCL Previously Treated with Ibrutinib 1:58
Copanlisib For People With Mcl Previously Treated With Ibrut...
2016
Long-Term Results of Ibrutinib/Umbralisib Show Efficacy in CLL and MCL 1:51
Long-term Results Of Ibrutinib/umbralisib Show Efficacy In C...
2021
Real-world data on previously untreated MCL in the US and the SHINE study 3:47
Real-world Data On Previously Untreated Mcl In The Us And Th...
2022
Updated results from the BRUIN study: pirtobrutinib in the treatment of MCL 1:59
Updated Results From The Bruin Study: Pirtobrutinib In The T...
2023
Rationale for Combining Acalabrutinib With Bendamustine and Rituximab in MCL 1:14
Rationale For Combining Acalabrutinib With Bendamustine And ...
2019
Advancements in MCL treatment 1:03
Advancements In Mcl Treatment
2022
Phase I/II study of zilovertamab and ibrutinib in MCL and CLL 9:26
Phase I/ii Study Of Zilovertamab And Ibrutinib In Mcl And Cl...
2024
Ibrutinib combined with TGR-1202 in CLL and mantle cell lymphoma (MCL): preliminary results 1:11
Ibrutinib Combined With Tgr-1202 In Cll And Mantle Cell Lymp...
2018
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.